Stocktoria
Ardent Health, Inc. ARDT
NYSE · stock · Services-General Medical & Surgical Hospitals, NEC · website · IPO 2024-07-18
Ardent Health, Inc. financials (annual)
Bars are annual figures from 2023 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $6.3B | $6.0B | $5.4B |
| Income tax | $56.2M | $63.4M | $22.6M |
| Net income | $135.8M | $210.3M | $53.9M |
| EPS (diluted) | $0.96 | $1.58 | $0.43 |
| Operating cash flow | $470.5M | $315.0M | $221.7M |
| Cash & equivalents | $709.6M | $556.8M | $437.6M |
| Inventory | $118.6M | $115.1M | $105.5M |
| Total assets | $5.3B | $5.0B | $4.7B |
| Total liabilities | $3.6B | $3.4B | $3.6B |
| Shareholders' equity | $1.7B | $1.5B | $1.1B |
Growth · year-over-year · Revenue CAGR 8.1%
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue growth | +6.0% | +10.3% | — |
| Net income growth | -35.4% | +290.2% | — |
| EPS growth | -39.2% | +267.4% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.